missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. CX3CR1 Rat anti-Human , BB515, Clone: 2A9-1, BD Biosciences™
  7. 17237494

CX3CR1 Rat anti-Human , BB515, Clone: 2A9-1, BD Biosciences™

Rat Monoclonal Antibody

Brand:  BD Biosciences 565902

 View more versions of this product

Product Code. 17237494

  • ONLINE EXCLUSIVE PRICE
    € 171.00
    € 169.38 / 25 tests
    Save € 1.62
    0.95% Off

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

CX3CR1 Monoclonal antibody specifically detects CX3CR1 in Human samples. It is validated for Flow Cytometry
TRUSTED_SUSTAINABILITY
Specifications

Specifications

CX3CR1
Monoclonal
Brilliant Blue 515 (BB515)
CCRL1; CMKBRL1; CMKDR1; GPR13; GPRV28; V28; Fractalkine Receptor
Human CX3CR1 Recombinant Protein
RUO
Human
IgG2b κ
Flow Cytometry
2A9-1
Aqueous buffered solution containing ≤0.09% sodium azide.
Rat
25 Tests
Primary
Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated with BD Horizon™ BB515 under optimum conditions and unconjugated antibody was removed.
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.